Skip to Content Facebook Feature Image

Sino Group and the Ng Teng Fong Charitable Foundation Support Non-Chinese Speaking Children and Promote Social Inclusion

Business

Sino Group and the Ng Teng Fong Charitable Foundation Support Non-Chinese Speaking Children and Promote Social Inclusion
Business

Business

Sino Group and the Ng Teng Fong Charitable Foundation Support Non-Chinese Speaking Children and Promote Social Inclusion

2024-07-23 16:28 Last Updated At:16:45

Partnership with Integrated Brilliant Education to Nurture Children of Different Ethnic Backgrounds

HONG KONG, July 23, 2024 /PRNewswire/ -- Sino Group ('the Group') and its philanthropic arm, Ng Teng Fong Charitable Foundation ('NTFCF'), have joined hands with Integrated Brilliant Education ('IBEL'), an educational non-government organisation (NGO), to provide support for students from different ethnic backgrounds in Hong Kong. With a shared vision to educate and empower children, this collaboration includes the provision of teaching resources for a new, inclusive kindergarten, which aims to enhance Chinese language proficiency from an early age and establish programmes designed to bridge educational and cultural experiences, fostering the integration of children with social and economic needs into the community.

Children from diverse ethnic backgrounds often experience educational difficulties, and language proficiency is crucial for overcoming educational challenges and facilitating social integration. IBEL is committed to empowering students from Non-Chinese Speaking (NCS) communities through Chinese language instruction and high-quality educational support, while also prioritising the development of social skills through interactive cultural activities, outings and events. IBEL's learning centres in Jordan and Sham Shui Po, established in 2015 and 2018 respectively, have supported over 30,000 students.

Mr Manoj Dhar, Co-founder and Chief Executive Officer of Integrated Brilliant Education and School Supervisor of IBEL Rusy and Purviz Shroff Charitable Foundation Kindergarten, said, 'As we celebrate our 10th anniversary, IBEL enters a new chapter with the establishment of our first kindergarten in Hong Kong. This milestone serves as a testament to our dedication to providing equal learning opportunities and welcoming underserved children from all backgrounds, transcending cultural boundaries. Collaborations and partnerships play a vital role in realising our vision of fostering inclusive education. We extend our gratitude to Sino Group and NTFCF for their invaluable support, enabling us to sustain our transformative work in providing early childhood education. Through this work, we equip children with essential Chinese language skills and also empower the community to come together to make a lasting difference.'

The newly-established IBEL Rusy and Purviz Shroff Charitable Foundation Kindergarten ('the kindergarten') has obtained its licence and commenced operations in April 2024, with new recruitment to come in the approaching academic year. To support the acquisition of teaching resources for the kindergarten, NTFCF has donated a total of HK$1.5 million over a span of three years.

In addition to education, Sino Group and NTFCF have been supporting IBEL's families since 2021 including the provision of care packs, children's masks and donations during COVID. The organisation's services have extended past the norm to also include culturally immersive experiences for their children as well, to deepen their understanding of Chinese culture and strengthen their sense of identity in Hong Kong. The experiences include in-depth explorations of the rich traditions and cultural heritage of the Lantau fishing village through visits to the Tai O Heritage Hotel and its surroundings, engaging festive workshops at The Fullerton Ocean Park Hotel during Chinese New Year, and educational visits to the CORAL REEFStoration Centre at Ocean Park.

Ms Nikki Ng, Director of Philanthropy of Sino Group and Director of the Ng Teng Fong Charitable Foundation, said, 'Promoting social inclusion is an important element of our sustainability principles. We have actively supported organisations that share our vision of empowering minority communities. We greatly appreciate IBEL's unwavering dedication to serving the non-Chinese speaking community in Hong Kong over the years. We are delighted to work together to foster children's understanding of Hong Kong and Chinese cultural values in an interactive and enjoyable environment. Personally, I had the pleasure of participating in activities with IBEL's students, and it was truly heartwarming to see the joy on their faces. It reminds us that even small efforts can have a positive impact in helping these children adapt, foster friendship across diverse backgrounds, broaden their horizons, and feel a greater sense of inclusion.'

Sino Group is committed to embracing diversity and promoting social inclusion, as outlined in its Sustainability Vision 2030. As part of this commitment, Sino Group has collaborated with local NGOs and community partners, including The Islamic Union of Hong Kong, Hong Kong Islamic Youth Association, Khalsa Diwan (Sikh Temple) of Hong Kong, The Kowloon Mosque, WEDO GLOBAL, and The Zubin Foundation, among others. From 2022 - 2023, Sino Group's efforts have benefited over 25,000 less-resourced elderly, children, youths, and 5,800 families, including those from diverse ethnic backgrounds, through 460 activities. Since 2013, we have been supporting NCS groups through various initiatives. For instance, during the holy month of Ramadan this year, NTFCF reached out to over 2,300 members of Hong Kong's Muslim community with Iftar meals and also extended support to 40 ethnically diverse students by providing them with eight months of free math tutorials at the Sikh Temple and Wanchai mosque.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Sino Group and the Ng Teng Fong Charitable Foundation Support Non-Chinese Speaking Children and Promote Social Inclusion

Sino Group and the Ng Teng Fong Charitable Foundation Support Non-Chinese Speaking Children and Promote Social Inclusion

ALL-RISE Study Included Over 1,924 Patients in 59 Sites Across 
North America, Asia, Europe and the Middle East

NEWPORT BEACH, Calif., Jan. 3, 2025 /PRNewswire/ -- CathWorks, a global leader in medical device digital health innovations, announced today the successful completion of enrollment of the Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment (ALL-RISE) randomized controlled trial (RCT). This landmark study represents a significant milestone in the field of interventional cardiology, evaluating the clinical and economic benefits of the CathWorks FFRangio® System in diagnosing and treating coronary artery disease (CAD), offering potentially groundbreaking evidence that could redefine the standard of care.

The ALL-RISE Study included over 1,924 patients across 59 sites in North America, Asia, Europe and the Middle East. Participants presenting with coronary stenoses of intermediate significance and requiring physiology assessment were randomized to receive either FFRangio-guided treatment or invasive pressure wire-guided treatment. Notably, this was the first-ever randomized controlled trial in the United States to assess clinical outcomes using an angiography-based tool for physiologic lesion assessment.

In a joint statement, the ALL-RISE Study Chair, Dr. Ajay J. Kirtane (NewYork-Presbyterian/Columbia University Irving Medical Center) and Principal Investigators, Dr. William Fearon (Stanford University) and Dr. Allen Jeremias (St. Francis Hospital & Heart Center), stated, "On behalf of the study executive committee, we would like to congratulate and thank all the global investigators, study coordinators and patients who collectively enabled this incredible accomplishment. The high level of engagement and record speed of enrollment parallel the growing adoption of FFRangio globally. We look forward to sharing the results of this landmark study after clinical follow-up is completed."    

CathWorks Sr. Director of Clinical Affairs, Alex Froimovich M.D., added, "The completion of ALL-RISE enrollment marks a significant milestone for our company and team's mission to transform how cardiovascular disease is diagnosed and treated. We believe this study, adding to FFRangio's growing body of clinical evidence, has the potential to significantly advance the field of coronary physiology and close the gap between its current adoption and the appropriate use guidelines recommendations. FFRangio has already demonstrated higher diagnostic accuracy over all other angio-based technologies, highlighting the fact that not all angio-based technologies are created equal, and therefore technology-specific clinical data are needed."

Cardiovascular disease (CVD) remains the leading cause of death in the United States. According to the American Heart Association's (AHA) 2024 Heart Disease and Stroke Statistics Update, CVD accounted for 931,578 deaths in the U.S. in 2021, and close to 18 million deaths globally. Coronary artery disease (CAD) is the single largest contributor, responsible for over 40% of CV deaths. CathWorks believes the results from the ALL-RISE study will build on what the company refers to as a new era in physiology, underscoring FFRangio as the new standard of care with the potential to drive better patient outcomes while delivering tangible economic and resource utilization benefits to healthcare systems.

ABOUT CATHWORKS

CathWorks is the leader in digital health innovations that can improve the lives of patients globally. The CathWorks FFRangio® System combines artificial intelligence and advanced computational science, transforming how cardiovascular disease is diagnosed and treated. The FFRangio System obtains physiologic information from routine angiograms, eliminating the need for drug stimulation and invasive pressure wires. It provides physicians with quick and reliable intraprocedural FFRangio values for the entire coronary tree. For more information on CathWorks, visit www.cath.works and follow @CathWorks on  LinkedIn

Investors:
Mike Feher
mike.feher@cath.works

Media:
Sarita Monico
sarita.monico@cath.works

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

Recommended Articles